LifeMD Inc. (LFMD)
LifeMD Statistics
Share Statistics
LifeMD has 44.58M shares outstanding. The number of shares has increased by 7.27% in one year.
| Shares Outstanding | 44.58M |
| Shares Change (YoY) | 7.27% |
| Shares Change (QoQ) | 2.94% |
| Owned by Institutions (%) | 38.24% |
| Shares Floating | 35.36M |
| Failed to Deliver (FTD) Shares | 117 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 7.41M, so 16.63% of the outstanding shares have been sold short.
| Short Interest | 7.41M |
| Short % of Shares Out | 16.63% |
| Short % of Float | 19.31% |
| Short Ratio (days to cover) | 8.69 |
Valuation Ratios
The PE ratio is -10.8 and the forward PE ratio is 32.33. LifeMD's PEG ratio is 0.44.
| PE Ratio | -10.8 |
| Forward PE | 32.33 |
| PS Ratio | 0.96 |
| Forward PS | 0.7 |
| PB Ratio | 0 |
| P/FCF Ratio | 11.64 |
| PEG Ratio | 0.44 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for LifeMD.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of -2.77.
| Current Ratio | 0.81 |
| Quick Ratio | 0.76 |
| Debt / Equity | -2.77 |
| Debt / EBITDA | -2.29M |
| Debt / FCF | 868.95K |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $698.86K |
| Profits Per Employee | $-62.11K |
| Employee Count | 304 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -402K |
| Effective Tax Rate | 2.19% |
Stock Price Statistics
The stock price has increased by -43.81% in the last 52 weeks. The beta is 2.23, so LifeMD's price volatility has been higher than the market average.
| Beta | 2.23 |
| 52-Week Price Change | -43.81% |
| 50-Day Moving Average | 5.63 |
| 200-Day Moving Average | 5.51 |
| Relative Strength Index (RSI) | 61.78 |
| Average Volume (20 Days) | 1.23M |
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M and earned -18.88M in profits. Earnings per share was -0.53.
| Revenue | 212.45M |
| Gross Profit | 242.4M |
| Operating Income | -16.14M |
| Net Income | -18.88M |
| EBITDA | -6.65M |
| EBIT | -16.14M |
| Earnings Per Share (EPS) | -0.53 |
Balance Sheet
The company has 35,004.9B in cash and 15,218.2B in debt, giving a net cash position of 19,786.8B.
| Cash & Cash Equivalents | 35,004.9B |
| Total Debt | 15,218.2B |
| Net Cash | 19,786.8B |
| Retained Earnings | -236,253.2B |
| Total Assets | 72.46M |
| Working Capital | -11.52M |
Cash Flow
In the last 12 months, operating cash flow was 17.51M and capital expenditures -11.54M, giving a free cash flow of 17.51M.
| Operating Cash Flow | 17.51M |
| Capital Expenditures | -11.54M |
| Free Cash Flow | 17.51M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 114.1%, with operating and profit margins of -7.6% and -8.89%.
| Gross Margin | 114.1% |
| Operating Margin | -7.6% |
| Pretax Margin | -8.63% |
| Profit Margin | -8.89% |
| EBITDA Margin | -3.13% |
| EBIT Margin | -7.6% |
| FCF Margin | 8.24% |
Dividends & Yields
LFMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for LFMD is $12, which is 97.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 97.4% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Oct 14, 2020. It was a backward split with a ratio of 1:5.
| Last Split Date | Oct 14, 2020 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | -0.76 |
| Piotroski F-Score | 4 |